Difference between revisions of "Part:BBa K5332000:Experience"
(→Applications of BBa_K5332000) |
|||
| Line 5: | Line 5: | ||
===Applications of BBa_K5332000=== | ===Applications of BBa_K5332000=== | ||
| + | Administering the engineered bacteria FMK designed by us to a mouse colitis model by gavage resulted in a recovery of colon length shortening, inhibition of immune cell recruitment, enrichment of beneficial bacteria in the gut, and an increase in gut microbiota diversity. The upregulation of pro-inflammatory factors and the downregulation of anti-inflammatory factors are also inhibited accordingly. The above results indicate that the gene element designed by our team can fully exert the expected results in the vector cell EcN and has good effects. | ||
===User Reviews=== | ===User Reviews=== | ||
Revision as of 18:17, 1 October 2024
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K5332000
Administering the engineered bacteria FMK designed by us to a mouse colitis model by gavage resulted in a recovery of colon length shortening, inhibition of immune cell recruitment, enrichment of beneficial bacteria in the gut, and an increase in gut microbiota diversity. The upregulation of pro-inflammatory factors and the downregulation of anti-inflammatory factors are also inhibited accordingly. The above results indicate that the gene element designed by our team can fully exert the expected results in the vector cell EcN and has good effects.
User Reviews
UNIQfec3d5e6677e6c54-partinfo-00000000-QINU UNIQfec3d5e6677e6c54-partinfo-00000001-QINU